Pre-clinical and clinical drug formulation development services

SP Formulations delivers a broad range of drug formulation development services for small and large molecules in a variety of pharmaceutical dosage forms including parenterals, liquids, and semi-solids.  SP Formulations provides superior value in drug development to its clients by rapidly delivering effective and robust formulations, accompanied by clear, concise, and timely communications.

As a member company of the internationally recognized research and testing leader, The Smithers Group,  SP Formulations has unique drug formulation development services and capabilities to support pre-clinical and clinical drug development for North America and Europe, with the personalized approach of a small contract research organization. For additional information on preclinical and clinical pharmaceutical analytical and bioanalytical services, including GMP- and cGMP-compliant testing, visit our sister company, Synomics Pharma.

Our quality management systems have been inspected by authorities in both North America and Europe, meeting FDA and EU regulations. SP Formulations is able to offer a full-service package for pre-clinical and clinical drug formulations, including analytical and manufacturing support.

White Papers

"Challenging the drug development blueprint: A formulator's perspective"

Dr. John Augustine, Formulations Manager, offers practical advice that can help to increase the likelihood of successful drug development. Click here to download the white paper.

A white paper titled "Semisolid Formulation Development: The CRO Approach", presents strategies which can be employed to develop a formulation more rapidly. Click here to download the paper.

A white paper from SP Formulations, titled "Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes", presents some of the problems associated with 'simple' formulation changes. Click here to download the white paper.